SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

Microsoft is facing intense downward pressure as investors grow increasingly skeptical of its high AI capital expenditures and the competitive threat to its core software business. The community is sharply divided, with many retail traders venting frustration over the stock's persistent, decoupling decline while others characterize the current valuation as a generational buying opportunity.

Destiny Tech100, Inc. operates as a non-diversified, closed-end management investment company. The company was founded on November 18, 2020 and is headquartered in Austin, TX.

Destiny Tech100 Inc

DESTINY TECH 100 INC

Destiny Tech100 is drawing significant investor interest as a high-concentration proxy for SpaceX, with market participants closely monitoring reports of an imminent IPO filing. The community is actively debating the fund's valuation relative to its NAV compared to other venture-focused investment vehicles, while anticipating that institutional demand for private unicorn exposure will drive further volatility.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

AppLovin is currently trading with extreme volatility as the community remains sharply divided between those calling for a broader structural breakdown and bulls pointing to the company's AI-driven advertising platform and upcoming fireside chat as key growth catalysts. The stock continues to be a battleground for retail traders, with ongoing debates centered on whether recent price swings are driven by coordinated short campaigns, insider selling, or institutional positioning ahead of sector rotation.

Kodiak Sciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of therapeutics for retinal diseases. Its product pipeline includes KSI-301 for wet AMD, KSI-301 for diabetic eye disease, KSI-501 for DME and uveitis, KSI-201 for resistant wet AMD, and KSI-401 for dry AMD. The company was founded by Stephen A. Charles and Victor Perlroth in 2009 and is headquartered in Palo Alto, CA.

Kodiak Sciences Inc

Kodiak Sciences is trending as investors react to positive Phase 3 results for Zenkuda in diabetic retinopathy, which met its primary endpoint and showed significant superiority over sham treatment. The community is actively debating the stock's potential for a broader repricing and recovery, closely monitoring institutional positioning from major stakeholders like Baker Bros against the backdrop of historical volatility and high short interest.

Wave Life Sciences Ltd. is a clinical-stage biotechnology company, which focuses on developing its proprietary RNA medicines platform and PRISM. It also develop and commercialize a pipeline RNA medicines in a variety of therapeutic areas. The company was founded by Gregory L. Verdine and Takeshi Wada on July 23, 2012 and is headquartered in Singapore.

Wave Life Sciences Ltd.

Wave Life Sciences Ltd

Wave Life Sciences is trending due to optimistic investor sentiment and analyst upgrades surrounding its obesity candidate, WVE-007, which has shown competitive fat loss results and muscle preservation in early clinical data. The community is actively discussing the stock's potential as a lucrative M&A target for major pharmaceutical firms, balancing excitement over its RNA platform against concerns regarding volatility, insider selling, and potential dilution from financing activities.

RAGE GUY (RAGE) is a cryptocurrency inspired by the Rage Guy meme, one of the earliest and most recognizable characters from internet rage comics. The project captures the cultural legacy of early meme history and brings it onto the blockchain in tokenized form. It is designed as a community-driven digital asset that celebrates internet culture, nostalgia, and the role memes play in shaping online communities.

Rage Guy

Rage Guy ($RAGE) is trending as the community doubles down on the revival of the iconic early 2000s meme culture, actively promoting its presence on the Solana network through community-driven building and comic creation. Enthusiasts are rallying behind the project as an 'OG' meme, emphasizing sustained daily engagement and the restoration of legacy web domains to solidify its place in internet history.

MARA Holdings, Inc. is a digital asset technology company, which engages in mining cryptocurrencies with a focus on the Bitcoin ecosystem. It also deals with owning and operating bitcoin mining facilities or data centers, selling proprietary software or technology to third parties operating in the Bitcoin ecosystem, offering advisory and consulting services to support Bitcoin mining ventures in domestic and international jurisdictions, and generating electricity from renewable energy resources or methane gas capture to power Bitcoin mining projects. The company was founded on February 23, 2010 and is headquartered in Hallandale Beach, FL.

MARA Holdings Inc.

Marathon Digital Holdings Inc

Marathon Digital Holdings is capturing significant investor attention as market participants debate its potential for a short squeeze amid high short interest and technical pressure near the $10 level. The community is sharply divided between those who view the stock as a deeply undervalued play on Bitcoin and AI infrastructure, and vocal critics who remain skeptical of leadership and the company's historical underperformance compared to sector peers.

WhiteFiber, Inc. provides AI and HPC infrastructure & cloud and data center solutions. It operates through the following segments: Cloud Services and Colocation Services. The Cloud Services segment offers computing services to support generative AI workstreams. The Colocation Services segment provides customers with physical space, power and cooling within the data center facility. The company was founded on August 15, 2024 and is headquartered in New York, NY.

Whitefiber Inc.

WhiteFiber, Inc.

WhiteFiber is currently trending as investors weigh strong AI data center demand against frustration over management's communication and the stock's recent volatility. While the community remains divided, many are focused on the company's potential to capitalize on the AI compute bottleneck, with active discussions centering on the long-term value of their infrastructure versus short-term price pressure and execution concerns.

Robinhood Ventures Fund I invest in companies located in the United States. The fund focuses on a broad range of sectors and industries. It provides financing for early stage transactions.

Robinhood Ventures Fund I - Common shares of beneficial interest

Robinhood Ventures Fund I (RVI) is experiencing significant market interest as traders debate its potential for explosive gains similar to other recently listed venture funds, while some investors remain focused on its private company exposure versus broader market volatility.

The Shrimp Army

SHRIMPS is gaining traction as part of a broader, community-led wave of ocean-themed meme coins on the Solana network, with traders actively debating its potential to erase zeros and mirror the rapid momentum of similar viral tokens. While some participants are hyping the asset for significant upside, others remain cautious, warning of high volatility and the risks of a rapid dump typical of speculative low-cap crypto projects.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Shares of Kodiak Sciences (KOD) jumped nearly 40% in pre-market trading on Thursday, after the pharmaceutical firm reported positive Phase 3 results for its eye drug Zenkuda to treat patients with diabetic retinopathy.The study met its primary endpoint as a total of 62.5% of patients treated with Zenkuda achieved at least a two-step improvement in DRSS score, a measure of severity, by week 48, compared with just 3.3% in the control group. The drug also reduced the risk of sight-threatening complications by 85% through Week 48.Zenkuda delivered consistent benefits regardless of GLP-1 use, with 60% of patients on GLP-1 therapies achieving a two-step DRSS improvement by Week 48, compared to 64.3% among those not using GLP-1 drugs. The treatment was well tolerated, with no cases of intraocular swelling and low rates of side effects.“We now have a multi-indication BLA-ready profile for Zenkuda, and we intend to accelerate our BLA submission plans,” said Victor Perlroth, CEO of Kodiak Sciences.Get updates to this developing story on Stocktwits.&nbsp;For updates and corrections, email newsroom[at]stocktwits[dot]com.

Tariff uncertainty has prompted several analysts to cut their price targets for Five9 stock. 

Why Did KOD Stock Surge 40% In Pre-Market Today?

The company said its Phase 3 trial to treat diabetic retinopathy met its primary endpoint.

Equity

Kodiak Sciences Announces Positive Topline Results in GLOW2, the Second Phase 3 Study in Diabetic Retinopathy, Demonstrating Superiority of Zenkuda (tarcocimab tedromer) Over Sham

Kodiak Sciences Announces Positive Topline Results in GLOW2, the Second Phase 3 Study in Diabetic Retinopathy, Demonstrating Superiority of Zenkuda (tarcocimab tedromer) Over Sham Kodiak Sciences Announces Positive Topline Results in GLOW2, the Second Phase 3 Study in Diabetic Retinopathy...

Kodiak Sciences (KOD) to Release Quarterly Earnings on Thursday

Kodiak Sciences (NASDAQ:KOD) will be releasing its Q4 2025 earnings before the market opens on Thursday, March 26. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-3-26-kodiak-sciences-inc-stock...

Boone Capital Management LLC Invests $11.72 Million in Kodiak Sciences Inc. $KOD

Boone Capital Management LLC bought a new position in shares of Kodiak Sciences Inc. (NASDAQ:KOD - Free Report) during the third quarter, according to its most recent Form 13F filing with the SEC...

Bruce & Co. Inc. Sells 43,692 Shares of Kodiak Sciences Inc. $KOD

Bruce & Co. Inc. decreased its position in shares of Kodiak Sciences Inc. (NASDAQ:KOD - Free Report) by 13.5% in the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned...

Investment Firm Doubles Down on Biotech Stock, Adds 386,000 Shares, According to Recent SEC Filing

Key PointsAcquired 386,000 shares of Kodiak Sciences (NASDAQ: KOD); estimated transaction value of $7.90 million based on quarterly average pricing...

TD Asset Management Inc Acquires New Stake in Kodiak Sciences Inc. $KOD

TD Asset Management Inc bought a new position in shares of Kodiak Sciences Inc. (NASDAQ:KOD - Free Report) during the 3rd quarter, according to the company in its most recent filing with the SEC. The...

Kodiak Sciences Inc. (NASDAQ:KOD) Receives Consensus Rating of "Moderate Buy" from Brokerages

Kodiak Sciences Inc. (NASDAQ:KOD - Get Free Report) has been assigned an average recommendation of "Moderate Buy" from the eight analysts that are currently covering the company, Marketbeat Ratings...

Kodiak Sciences Stock Up 480% as One Fund Discloses $53 Million Buy

Key PointsBaker Bros. Advisors increased its Kodiak Sciences stake by 2,608,696 shares; the estimated trade size was $53.42 million...

Kodiak Sciences (NASDAQ:KOD) Shares Down 5.9% - Here's What Happened

Kodiak Sciences (NASDAQ:KOD) Stock Price Down 5.9% - What's Next...

Traders are reacting to positive Phase 3 clinical trial results for Zenkuda showing significant improvement in diabetic retinopathy patients.

KOD
Kodiak Sciences Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest KOD News

KODKodiak Sciences Inc